Immune dysregulation and self-reactivity in schizophrenia: do some cases of schizophrenia have an autoimmune basis? - PubMed (original) (raw)
Review
Immune dysregulation and self-reactivity in schizophrenia: do some cases of schizophrenia have an autoimmune basis?
Amanda L Jones et al. Immunol Cell Biol. 2005 Feb.
Free article
Abstract
Schizophrenia affects 1% of the world's population, but its cause remains obscure. Numerous theories have been proposed regarding the cause of schizophrenia, ranging from developmental or neurodegenerative processes or neurotransmitter abnormalities to infectious or autoimmune processes. In this review, findings suggestive of immune dysregulation and reactivity to self in patients with schizophrenia are examined with reference to criteria for defining whether or not a human disease is autoimmune in origin. Associations with other autoimmune diseases and particular MHC haplotypes, increased serum levels of autoantibodies, and in vivo and in vitro replication of some of the functional and ultrastructural abnormalities of schizophrenia by transfer of autoantibodies from the sera of patients with schizophrenia suggest that, in some patients at least, autoimmune mechanisms could play a role in the development of disease. Recent findings regarding specific autoimmune responses directed against neurotransmitter receptors in the brain in patients with schizophrenia will also be reviewed.
Similar articles
- Autoimmunity and schizophrenia: an epiphenomenon or an etiology?
Amital H, Shoenfeld Y. Amital H, et al. Isr J Med Sci. 1993 Sep;29(9):593-7. Isr J Med Sci. 1993. PMID: 8225948 Review. - Autoimmunity in schizophrenia: a review of recent findings.
Ganguli R, Brar JS, Chengappa KN, Yang ZW, Nimgaonkar VL, Rabin BS. Ganguli R, et al. Ann Med. 1993 Oct;25(5):489-96. doi: 10.3109/07853899309147317. Ann Med. 1993. PMID: 8251150 Review. - [Anti-somatostatin autoantibodies in the blood serum of patients with schizophrenia].
Rogaeva EA, Chumakova MM, Dergunova NN, Pozharitskaia DA, Kopeĭko GI, Tsutsul'kovskaia MIa, Tsibezov VV. Rogaeva EA, et al. Zh Nevropatol Psikhiatr Im S S Korsakova. 1990;90(7):82-4. Zh Nevropatol Psikhiatr Im S S Korsakova. 1990. PMID: 1979460 Russian. - The case for autoimmunity in the etiology of schizophrenia.
Goldsmith CA, Rogers DP. Goldsmith CA, et al. Pharmacotherapy. 2008 Jun;28(6):730-41. doi: 10.1592/phco.28.6.730. Pharmacotherapy. 2008. PMID: 18503401 Review. - Schizophrenia and autoimmunity--a possible etiological mechanism?
Noy S, Achiron A, Laor N. Noy S, et al. Neuropsychobiology. 1994;30(4):157-9. doi: 10.1159/000119155. Neuropsychobiology. 1994. PMID: 7862263 Review.
Cited by
- Network-based drug repurposing for schizophrenia.
Truong TTT, Liu ZSJ, Panizzutti B, Kim JH, Dean OM, Berk M, Walder K. Truong TTT, et al. Neuropsychopharmacology. 2024 May;49(6):983-992. doi: 10.1038/s41386-024-01805-6. Epub 2024 Feb 6. Neuropsychopharmacology. 2024. PMID: 38321095 Free PMC article. - Causal link between thyroid function and schizophrenia: a two-sample Mendelian randomization study.
Freuer D, Meisinger C. Freuer D, et al. Eur J Epidemiol. 2023 Oct;38(10):1081-1088. doi: 10.1007/s10654-023-01034-z. Epub 2023 Aug 17. Eur J Epidemiol. 2023. PMID: 37589836 Free PMC article. - Schizophrenia Synaptic Pathology and Antipsychotic Treatment in the Framework of Oxidative and Mitochondrial Dysfunction: Translational Highlights for the Clinics and Treatment.
De Simone G, Mazza B, Vellucci L, Barone A, Ciccarelli M, de Bartolomeis A. De Simone G, et al. Antioxidants (Basel). 2023 Apr 21;12(4):975. doi: 10.3390/antiox12040975. Antioxidants (Basel). 2023. PMID: 37107350 Free PMC article. Review. - Linking Inflammation, Aberrant Glutamate-Dopamine Interaction, and Post-synaptic Changes: Translational Relevance for Schizophrenia and Antipsychotic Treatment: a Systematic Review.
de Bartolomeis A, Barone A, Vellucci L, Mazza B, Austin MC, Iasevoli F, Ciccarelli M. de Bartolomeis A, et al. Mol Neurobiol. 2022 Oct;59(10):6460-6501. doi: 10.1007/s12035-022-02976-3. Epub 2022 Aug 13. Mol Neurobiol. 2022. PMID: 35963926 Free PMC article. Review. - DNA Methylation Basis in the Effect of White Matter Integrity Deficits on Cognitive Impairments and Psychopathological Symptoms in Drug-Naive First-Episode Schizophrenia.
Zong X, Zhang Q, He C, Huang X, Zhang J, Wang G, Lv L, Sang D, Zou X, Chen H, Zheng J, Hu M. Zong X, et al. Front Psychiatry. 2021 Dec 13;12:777407. doi: 10.3389/fpsyt.2021.777407. eCollection 2021. Front Psychiatry. 2021. PMID: 34966308 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials